No information is available on the clinical use of ritlecitinib during breastfeeding. The manufacturer recommends that breastfeeding be discontinued during ritlecitinib therapy and for 14 hours after the last dose.
关于利特昔替尼在母乳喂养期间的临床应用尚无可用信息。制造商建议在利特昔替尼治疗期间及最后一剂后14小时内停止母乳喂养。
